SB431542, SB 431542|

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

23 API Suppliers, 4 USDMF, 1 EU WC, 1 KDMF, 4 NDC API, 18 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

13 Drugs in Development

13 Drugs in Development

INTERMEDIATES

16 Intermediate Suppliers

16 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

23 FDF Dossiers, 5 FDA Orange Book, 8 Europe, 2 Canada, 4 Australia, 2 South Africa, 2 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 8 DKSH, 1 Faran Shimi Pharmaceutical, 2 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 BASF, 2 DFE Pharma, 1 Finar, 6 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 3 Kerry, 3 Lonza Capsugel, 7 Microlex e.U, 1 Pharmatrans-Sanaq, 1 Pluviaendo, 2 Prachin Chemical, 1 Qualicaps, 9 Roquette, 1 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 8 Sigachi Industries, 2 Silverline Chemicals, 1 Valens Pharmachem, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

23 Fillers, Diluents & Binders, 15 Thickeners and Stabilizers, 10 Lubricants & Glidants, 9 Direct Compression, 8 Coating Systems & Additives, 8 Empty Capsules, 5 Co-Processed Excipients, 5 Film Formers & Plasticizers, 5 Granulation, 4 Disintegrants & Superdisintegrants, 4 Emulsifying Agents, 3 Taste Masking, 3 Coloring Agents, 3 Topical, 3 Controlled & Modified Release, 2 Solubilizers, 2 Chewable & Orodispersible Aids, 1 Parenteral, 1 API Stability Enhancers, 1 Rheology Modifiers